Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris

References

• Smith SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO, et al. ACC/AHA Guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)–executive summary. Circulation 2001; 103: 3019–3041
   PubMed Web of Science ®Google Scholar
• Califf RN, Fortin DF, Frid DJ, Harlan WR, 3rd, Ohman EM, Bengtson JR, Nelson CL, Tcheng JE, Mark DB, Stack RS. Restenosis after coronary angioplasty: An overview. J Am Coll Cardiol 1991; 17: 2–13B
   Google Scholar
• Fitzgerald DJ, Roy I, Catella F, FitzGerald GA. Platelet activation in unstable angina. New Engl J Med 1986; 315: 983–989
   PubMed Web of Science ®Google Scholar
• Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D’Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001; 21: 327–334
   PubMed Web of Science ®Google Scholar
• Schwager I, Jungi TW. Effect of recombinant cytokines on the induction of macrophage procoagulant activity. Blood 1994; 83: 152–161
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Ott I, Marx N, Luther T, Kenngott S, Gawaz M, Kotzsch M, Schomig A. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997; 17: 3399–3405
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Deward B, Moster B. Interleukin-8 and related chemotactic cytokines–CXC and CC chemokines. Adv Immunol 1994; 55: 97–179
   PubMed Web of Science ®Google Scholar
• Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176: 587–592
   PubMed Web of Science ®Google Scholar
• Holme PA, Muller F, Solum NO, Brosstad F, Froland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in HIV-1 infection. FASEB J 1998; 12: 79–89
   PubMed Web of Science ®Google Scholar
• Matsumoto N, Nomura S, Kamihata H, Kimura Y, Iwasaka T. Association of platelet-derived microparticles with C-C chemokines on vascular complication in patients with acute myocardial infarction. Clin Appl Thromb Hemost 2002; 8: 279–286
   PubMed Web of Science ®Google Scholar
• Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, Kimura Y. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost 2003; 89: 506–512
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis–An inflammatory disease. New Engl J Med 1999; 340: 115–126
   PubMed Web of Science ®Google Scholar
• Butcher EC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991; 67: 1033–1036
   PubMed Web of Science ®Google Scholar
• Inoue T, Sakai Y, Fujito T, Hoshi K, Hayashi T, Takayanagi K, Morooka S. Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis. Thromb Haemost 1998; 79: 54–58
   PubMed Web of Science ®Google Scholar
• Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus ballon angioplasty for stable angina pectoris. Am J Cardiol 2000; 86: 1057–1062
   PubMed Web of Science ®Google Scholar
• Inoue T, Uchida T, Yaguchi I, Sakai Y, Takayanagi K, Morooka S. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 2003; 107: 1757–1763
   PubMed Web of Science ®Google Scholar
• Welt FGP, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002; 22: 1769–1776
   PubMed Web of Science ®Google Scholar
• Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, Gioffre PA. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 1998; 82: 515–518
   PubMed Web of Science ®Google Scholar
• Bahrmann P, Sigusch HH, Surber R, Figulla HR. Oral antiplatelet therapies have no effect on circulating levels of RANTES in patients with coronary artery disease. Pharmazie 2002; 57: 863–864
   PubMedGoogle Scholar
• Welt FG, Rogers SD, Zhang X, Ehlers R, Chen Z, Nannizzi-Alaimo L, Phillips DR, Simon DI. GPIIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention. Catheter Cardiovasc Interv 2004; 61: 185–189
   PubMed Web of Science ®Google Scholar
• Schober A, Manka D, von Hundelshausen P, Huo Y, Hanrath P, Sarembock IJ, Ley K, Weber C. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 2002; 106: 1523–1532
   PubMed Web of Science ®Google Scholar